• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Mad Hedge Fund Trader

The Final Word on the Tax "Wash Sale" Rule

Diary, Newsletter, Research

Yes, it?s time for another boring tax story. And April 15 is still seven months off, so I can?t even use a tax-filing deadline as an excuse.

However, due to the immense volume of profitable trades the Mad Hedge Fund Trader Alert Service executed in September, I am getting a lot of questions about the dreaded ?Wash Sale? Rule.

The wash what?

The problem arises because the Internal Revenue Service believes that taxpayers are on a never-ending quest to avoid paying taxes. In that belief the despised government agency is largely right.

So what is the wash sale rule?

Let?s say you purchase 100 shares of XYZ Corp. for $25 per share on February 10. Nine days later, on February 19, XYZ drops to $22 per share and you sell your 100 shares.

You now have a capital loss of $3 per share, or $300, which may be tax-deductible.

However, if, on February 26, you then bought the same security for $22.50 per share, this would be considered a ?Wash Sale? because you sold and repurchased shares of the same stock within only a few days.

Without the wash sale rule, the result would be that you could possibly have a tax deduction for your loss, but you would still own the shares, which is why it's called an "artificial" loss by the IRS, and therefore not deductible as a capital loss.

Don?t try hiding your maneuvers by executing one leg of the trade in your personal account, and the second in your wife?s account or your IRA. Both actions still trigger the Wash Sale Rule.

The rule applies whether you are trading stocks, exchange traded funds, mutual funds, or options on any of the above. In fact, wash sales are quite likely if you have arranged for automatic reinvestment of your dividends back into your mutual funds.

The only requirement is that the two securities be substantially similar in nature, the precise definition of which the IRS has left intentionally and maddeningly vague.

The Wash Sale Rule becomes an issue with the vertical bull call and bear put spreads the Mad Hedge Fund Trader has been recommending.

Usually, you are long one option and short another in the same company and both legs generate a profit on closing. No problem there. You just pay more in taxes and hope the government doesn?t blow it on some useless program.

But during periods of extreme volatility, such as August and September, 2015, it is possible to have a large gain on one leg, a substantial loss on the other, but to have a profit overall on the combined paired spread.

Enter the Wash Sale Rule.

Since you had gains and losses in nearly identical securities within 30 days, the IRS will hit you with a short term gain on the profit, but not let you deduct the loss.

Yes, I know this sounds like a rip off, or a ?heads I win, tails you lose? scam perpetrated by a devious IRS.

But it is not the end of the world. NO, I have not designed the most tax inefficient securities trading strategy imaginable.

While you can?t deduct the loss on the losing leg, you CAN use it to increase the cost basis on your winning leg, thus reducing your overall tax bill.

Also, the holding period of the wash sale securities is added to the holding period of the replacement securities.

Do this enough times, and you will eventually make it to the safety and the lower 20% tax rate for long-term capital gains. In this manner, the Wash Sale Rule then becomes a convenient tax avoidance scheme, although it was certainly never intended as such.

So the losses ARE deductible at the end of the day. You just have to get your accountant to undergo some mental gymnastics and file the appropriate IRS Form 8949 to claim them indirectly.

He?ll charge you for the extra time. But at the end of the day, it is worth it.

As I am an ?active trader? to say the least, in my case these filings go on for dozens of pages. As a result, my annual tax return looks like the New York City telephone book.

Actually, I?m told it?s the same length as the corporate return filed by IBM.

Now here are some warnings and provisos for the average taxpayer.

If you use your friendly neighborhood tax preparer, one of the discount firms like H&R Block or Jackson Hewitt, or your fraternity brother from college using TurboTax to file your annual return, they may not know how to handle Wash Sales correctly.

You could well get stuck with the full loss because of their ignorance.

So if you are an active trader yourself, or are dealing in large dollar amounts, I would recommend hiring an accountant who specializes in securities trading.

They will have all of the detailed knowledge readily at hand of the many obscure, arcane tax laws regarding securities trading, know of the recent relevant opinion letters issued by the IRS, and will be well aware of court cases regarding these issues.

Experts such as these can be found in abundance in New York and Chicago. They are easy to find on the Internet. Go to it.

Having spent 45 years dealing with tax matters, and devoting 10 years writing a weekly international tax column for the London Financial Times, I can tell you this is not a new problem.

Ignorance of tax problems outside of the plain vanilla questions is rife, even among accountants (yes, Sunday church deductions are tax deductible. Just make them by check so you leave an auditable paper trail).

There is no living person who knows what?s in the entire 100,000 pages of the Internal Revenue Code, not even the IRS itself.

That?s a scary thought.

During the 1980s, the IRS sent an agent to England every year just to audit me because I was one of the ten highest earning Americans in the country.

For the last audit they sent a frumpy, bespectacled agent who had just spent a month auditing roustabouts on drilling platforms offshore from Louisiana, a notorious source of tax avoidance.

She didn?t have a clue about how to interpret my multicurrency convertible home mortgage on my London mansion, so we spent the afternoon at the American embassy planning her European vacation to follow.

I think I heard the CIA torturing someone in the next room.

Similarly, when I went into the oil and gas business in the 1990s, no California accountant could explain the tax benefits of that industry. I had to go to Houston to learn that, and what I discovered was a real eye opener.

Why isn?t everyone in the oil and gas business?

To learn about my last run in with the IRS, read ?The Letter From the IRS You Should Dread?.

For more background on the IRS, read ?Happy Birthday IRS?.

To get the official explanation of the Wash Sale Rule in the IRS?s own turgid, soporific bureaucratese, IRS Publication 550, see ?Investment Income and Expenses (Including Capital Gains and Losses)?.

Tax FormsWatch Out for the ?Wash Sale? Rule

https://www.madhedgefundtrader.com/wp-content/uploads/2015/10/Tax-Forms-e1445001594960.jpg 264 400 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2016-09-08 01:06:392016-09-08 01:06:39The Final Word on the Tax "Wash Sale" Rule
DougD

September 7, 2016

Diary, Newsletter, Summary

Global Market Comments
September 7, 2016
Fiat Lux

Featured Trade:
(HOW SOON WILL THE FED BUY STOCKS?),
(TESTIMONIAL)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 DougD https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png DougD2016-09-07 01:08:002016-09-07 01:08:00September 7, 2016
DougD

How Soon Will the Fed Buy Stocks?

Diary, Newsletter

The media focused with laser-like intensity on Janet Yellen?s move towards a decidedly more hawkish position on interest rates at her August 26th Jackson Hole speech.

However, they missed her most important comments.

I didn?t.

I am specifically referring to her speculation about what forms Fed stimulus will take during the next recession, whenever that is. After all, that was the principal topic at the confab of central bankers, economists, and academics.

Fed watchers were suitably awed by the prospect of another $2 trillion of quantitative easing that was promised.

And remember, this will take place only after the Fed moves US interest rates to negative numbers, something I expect to take place within the next three years.

But what really caught my attention was her reference to widespread purchases of ?alternative assets.? This is the dog whistle for government buying of US corporate bonds and stocks.

There is a long history of governments investing in their own stock markets during times of financial duress, some of which I have been directly involved with.

During the Asian financial crisis in 1997, initially triggered by the crash of the Thai Baht, the Hong Kong stock market collapsed to the point where several of the colony?s leading companies were at risk of going under.

With the British handover back to China imminent, capital fled the crown colony by the boatload.

Right at the market bottom, the government stepped in with a $15 billion support operation that focused on the largest share listings. Over the following 18 months, the Hang Seng share prices index soared by an incredible 176%.

The government then unloaded its entire holdings through a convertible bond offering with a 5% premium right before the 2000 dotcom bubble bust.

A more recent example can be found in the Bank of Japan?s expansion of its hyper aggressive quantitative easing in March, 2015 to include $60 billion worth of equity backed exchange traded funds.

The program was so ambitious that the government is now the largest shareholder in the top 50 Japanese companies.

Here the results were much less impressive. The Nikkei Index has so far fallen -28%.

But Japan also has faced gale force headwinds in the form of a relentlessly appreciating Japanese yen during this time, which is always bad news for Japanese stocks. Higher prices always mean fewer exports and even fewer profits.

Other countries buy stocks when their bond markets are too small and illiquid for central banks to have any real influence on the economy, such as in the Czech Republic.

And here?s another hint for you. What was Fed vice chairman Stanley Fischer?s last job? He was governor of the Bank of Israel, another country where the central bank has been active in soaking up equities.

So which shares will America?s central bank buy? You can count on the S&P 500 (SPY) shares to be the principal target.

How much could the Fed pour into our $23 trillion stock market? $1 trillion is doable, but it could be more, depending on the severity of the next recession.

And what about the market impact? As the Hong Kong and Japanese experiences have shown, long-term fundamentals are always a much more important driver of equity valuations than any short-term liquidity events.

Even the Fed can only put so much lipstick on a pig.

You could expect a nice ?rip your face off? short covering rally worth 5% when the headline hits.

Believe it or not, this is not a new idea. The George W. Bush administration proposed privatizing Social Security during the 2000s.

If carried out, it would have placed a major portion of our retirement funds into equities just before the 2008 financial crisis and stock market crash.

Thank goodness for small mercies that Bush never got the votes in congress to pull this off.

Future quantitative easing might not be necessary if Clinton wins the House of Representatives in November.

That would end the logjam in Washington, and open the way for $2 trillion in infrastructure spending, which the country sorely needs.

The Fed can then finally put its QE policy to bed, although it will take another eight years for it to run down it?s $3.4 trillion in existing Treasury bond holdings.

But at this point, there is only a 50-50 chance that Clinton can pull off this electoral trifecta.

She is overwhelming ahead in every battleground state (NV, AZ, CO, IA, WI, MI, OH, GA, FL, PA, NH, NC), in some cases by double digits which will give her a huge win in the Electoral College.

But because of gerrymandering in several key states, Clinton needs to win 57% of the national vote to win a majority of House seats.

Ask me again in November how doable this really is. I?ve only been watching presidential elections for a half century, so I?m still getting the hang of it.

Still, given my prediction that US stocks could rise by 17 times over the next 20 years, government purchases of stocks might not be such a bad idea.

It certainly would have merit if they step into the market after a long valuation slide. Price earnings multiples bottomed out at 9X in 2009 during the financial crisis, compared to 20X today.

?It could then unwind its positions going into the next bubble top.

Buy low, sell high, it sounds like a plan to me. It is a performance that could put the old Hong Kong colony government?s market timing to shame.

In fact, it could be the best investment the government ever makes.

And if the Fed is buying stocks, the European Central Bank won?t be far behind, if it doesn?t get there first. The ECB is already near to exhausting markets with bond purchases as part of its own QE.

Stocks could be the new, rising asset class of not just the US, Japan, and Europe, but ALL central banks.

Did someone just mention the term ?global synchronized bull market?

To learn the fundamental economic arguments behind my bullish two decade forecasts, please read my just released book, ?Stocks to Buy for the Coming Roaring Twenties?.

$HSI$NIKK
Japan - Assets of the CB
Janet Yellen6

Future US Stock Investor?

https://www.madhedgefundtrader.com/wp-content/uploads/2016/09/Janet-Yellen6-e1473201926182.jpg 267 400 DougD https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png DougD2016-09-07 01:07:142016-09-07 01:07:14How Soon Will the Fed Buy Stocks?
DougD

September 6, 2016

Diary, Newsletter, Summary

Global Market Comments
September 6, 2016
Fiat Lux

Featured Trade:
(MARKET OUTLOOK FOR THE COMING WEEK),
(SPY), (TLT), (FXE), (FXY), (USO), (CU),
?(INDUSTRIES YOU WILL NEVER HEAR FROM ME ABOUT)

SPDR S&P 500 ETF (SPY)
iShares 20+ Year Treasury Bond (TLT)
CurrencyShares Euro ETF (FXE)
CurrencyShares Japanese Yen ETF (FXY)
United States Oil (USO)
First Trust ISE Global Copper ETF (CU)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 DougD https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png DougD2016-09-06 01:08:152016-09-06 01:08:15September 6, 2016
DougD

Market Outlook for the Coming Week

Diary, Newsletter

I?m presently dancing to the song ?Believe? by Cher, my former next-door neighbor, and the top hit of 1999 that dominated the airwaves.

I am not particularly a fan of late twentieth century music, even by Cher.

However, I definitely think the markets are replaying the years 1998-1999.

That means stocks keep rising for a least another one to two years on the back of improving corporate earnings, ultra low interest rates, and expanding price/earnings multiple.

Dow 21,000 is a chip shot, as is S&P 500 2,400. The great bull market will extend well into 2018 and maybe even 2019.

You heard it here first.

Much more fascinating, to me anyway, were asset class reactions to the August Non Farm Payroll released on Friday.

There is no doubt that the 151,111 print was a big disappointment, well below the 180,000 consensus forecast.

The headline unemployment rate stayed at a decade low 4.9%, while the structural unemployment U-6 fell to 9.7%.

Food Services picked up +35,000 jobs, Social Assistance +22,000, and Professional and Tech Services +20,000. Manufacturing lost -14,000, typical of summer layoffs.
?
This should have triggered a major ?RISK ON? move, as the chance of a Fed rate hike on in September was totally obliterated, and interest rates will remain lower for longer.

However, after the first five minutes, we saw a decidedly ??RISK OFF? move ensue.

Stocks (SPY), bonds (TLT), foreign currencies (FXY), (FXE) and copper (CU) all fell in unison. Oil (USO) rose, but it seems to be living in it's own, geopolitically driven world now.

So, even though the short-term risk of a rate rise is now gone, and maybe even a medium term tightening in December, markets seems to be focused on the long term direction of rates which is definitely upward.

Of course, rates will rise so slowly as to be imperceptible, because deflation is still rampant, globally so. So that keeps the bull market in stocks alive and well. This one could run for a record 8-9 years.

Talk about getting to ?Have your cake and eat it too.?

By the way, those who took my advice to sell short the Treasury bond market with my last two Trade Alerts are home free.

We are now probing the bottom end of a two-month trading range and have only nine days left until the September 16 expiration. I just checked prices and we are marking at 70% of the maximum potential profit in our last position.

Well done!

Thanks to Labor Day, we have a mercifully shortened week, with the major economic data reports behind us.

On Tuesday, September 6 at 8:30 AM EST we receive Gallup Consumer Spending which should continue moving from strength to strength. Never underestimate Americans? willingness to spend money, especially on credit.

On Wednesday, September 7 at 10:00 AM we see the Fed Beige Book which will confirm a continuing slow 2% growth rate.

On Thursday, September 8 at 8:30 AM EST the Weekly Jobless Claims should confirm that employment remains at decade highs. We will also get a series of Treasury auctions which should be weak, given today?s market response.

On Friday, September 9 at 1:00 PM EST we wind up with the Baker Hughes Rig Count. Worryingly, the trend has been up for the past two months, driving oil prices lower.

Overall, I expect all markets to continue to trend sideways in narrow ranges until the next Fed Open Market Committee Meeting on September 20.

I throw in the chart below that has been circulating on the Internet today showing where we are with the ?Buffet Indicator.? This is the measure of the value of corporate equities to nominal GDP.

Although it is still a few years off, it is approaching the 2000 bubble top high. Of course, near zero interest rates skew everything, so the next high should be much loftier than the last one.

You heard that here first too.

Is that ?Believe? I hear ringing in my ears again?

Pick your poison!
The Buffett Indicator SPY TLT FXY
Cher

Are the Nineties Making a Comeback?

https://www.madhedgefundtrader.com/wp-content/uploads/2016/09/Cher-e1472845964599.jpg 363 400 DougD https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png DougD2016-09-06 01:07:482016-09-06 01:07:48Market Outlook for the Coming Week
DougD

September 2, 2016

Diary, Newsletter, Summary

Global Market Comments
September 2, 2016
Fiat Lux

Featured Trade:
(LAS VEGAS NOVEMBER 18th GLOBAL STRATEGY LUNCHEON),
(MAD HEDGE FUND TRADER HITS NEW ALL TIME HIGH),
(FXY), (YCS), (FXE), (EUO), (TLT), (TBT), (VIX),

(BIOTECH AND HEALTH CARE STOCKS TO BUY AT THE BOTTOM),
(GILD), (AMGN), (BIIB), (REGN), (HCA),
?(MYL), (CELG), (AGN), (XLV), (IBB)

CurrencyShares Japanese Yen ETF (FXY)
ProShares UltraShort Yen (YCS)
CurrencyShares Euro ETF (FXE)
ProShares UltraShort Euro (EUO)
iShares 20+ Year Treasury Bond (TLT)
ProShares UltraShort 20+ Year Treasury (TBT)
VOLATILITY S&P 500 (^VIX)
Gilead Sciences Inc. (GILD)
Amgen Inc. (AMGN)
Biogen Inc. (BIIB)
Regeneron Pharmaceuticals, Inc. (REGN)
HCA Holdings, Inc. (HCA)
Mylan N.V. (MYL)
Celgene Corporation (CELG)
Allergan plc (AGN)
Health Care Select Sector SPDR ETF (XLV)
iShares Nasdaq Biotechnology (IBB)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 DougD https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png DougD2016-09-02 01:09:282016-09-02 01:09:28September 2, 2016
DougD

Mad Hedge Fund Trader Hits New All Time High

Diary, Newsletter

I have been on one heck of a hot streak, and boy do I like it!

What a difference a vacation makes.

Since I returned from my summer headquarters in Zermatt, Switzerland on July 28, every single Trade Alert I have sent you has been profitable.

August was a perfect month, taking in a lip smacking 7.52%. In fact, 91% of my recommendation have proved profitable since June 9, nearly three months ago.

Was it summiting the Matterhorn for the fourth time that did it? Or perhaps it was floating down the Rhine through Basel, kept afloat only by my wicklefische, which I had bought at a discount.

I bet a day spent at the historic, clothing optional Friedrichsbad steam baths in Baden Baden had something to do with it.

Whatever the reason, my subscribers are happy. Those who became members from August onward think I?m some sort of genius.

I began with the assumption that financial markets would remain trapped in narrow ranges for the summer.

The markets are going to new all time highs on the back of a Clinton win in November. But they had to take a break first.

What we are getting is not a ?price correction,? but a ?time correction" whereby prices grind sideways before breaking out to the upside.

Whether that will happen before or after the September 20 Federal Open Market Committee (FOMC) meeting is anyone?s guess.

So I sold short the S&P 500 (SPY), the Japanese yen (FXY), (YCS), the Euro (FXE), (EUO), and Treasury bonds (TLT), (TBT).

For good measure, I also bought the Volatility Index (VIX) while it was trading at a decade low. Every position turned profitable.

This brings my 2016 year to date performance up to 14.01%, compared to 5.85% for the S&P 500. The trailing 12 month return is 21.69%

My six year return now reaches an eye popping 205.69%, delivering an average annualized return of 35.77%.

These are numbers that any financial advisor, hedge fund manager or retiree trading from home would kill for.

Those who have made the effort to wake up early every morning and read my witty and incisive prose have an impressive row of notches on their bedpost to show for their effort.

My groundbreaking trade mentoring service was first launched in 2010. Thousands of subscribers now earn a full time living solely from my Trade Alerts, a development of which I am immensely proud.

Some 50% of my clients are over 50 and managing their own retirement funds, fleeing the shoddy and expensive services provided by Wall Street. The balance is institutional investors, hedge funds, and professional financial advisors.

The Mad Hedge Fund Trader seeks to level the playing field for the average Joe. Looking at the testimonials that come in every day, I?d say I'm accomplishing that goal.

Quite a few followers were able to move fast enough to cash in on my trading recommendations. To read the plaudits yourself, please go to my testimonials page by clicking here .

Our business is booming, so I am plowing profits back in to enhance our added value for you.

And now for the rest of the year.

I can?t wait!

John Thomas
Publisher and CEO
The Mad Hedge Fund Trader

201.69% Trailing 12 Month

This is How You Do It
21.69% Trailing 12 Month Return

35.77% AAR35.77% Average Annualized Return

John at Ship Steering WheelLet Me Steer You to Trading Profits

https://www.madhedgefundtrader.com/wp-content/uploads/2016/08/John-at-Ship-Steering-Wheel-e1470707345318.jpg 400 389 DougD https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png DougD2016-09-02 01:07:232016-09-02 01:07:23Mad Hedge Fund Trader Hits New All Time High
Mad Hedge Fund Trader

Biotech and Health Care Stocks to Buy at the Bottom

Diary, Newsletter, Research

One has to be truly impressed with the selloff in biotech and health care stocks over the past year.

Since May, there were signs that life was returning to this beleaguered sector. Then Mylan decided to raise the prices of it's EpiPen by 400% and it was back to the penalty box.

Let?s gouge poor small children who may die horrible deaths if they can?t afford our product. That sounds like a great marketing and PR strategy. NOT!

Once the top performing sectors of 2015, they went from heroes to goats so fast, it made your head spin.

What I called ?The ATM Effect? kicked in big time.

That?s when frightened investors run for the sidelines and sell their best stocks to raise cash. After all, no one wants to sell other stocks for a loss and admit defeat, at least in front of their clients.

It?s not that the companies themselves were without blood on their hands. Valuations were getting, to use the polite term, ?stretched? after a torrid five-year run.

Gilead Sciences (GILD) soaring from $18 to $125?

Celgene (CELG) rocketing from $20 to $142?

It has been a performance for the ages.

If a financial advisor wasn?t in health care, chances are that he is driving for Uber in a bad neighborhood by now.

Then there was The Tweet That Ate Wall Street.

Presidential candidate Hillary Clinton made clear in a broadcast on September 21, 2015 that the health care industry would be target number one in her new administration.

Her move was triggered by an overnight 5000% price hike for a specialty HIV drug by a minor player in the industry.

Among the reforms she would implement are:

1) Give the government power to negotiate drug purchases with the industry collectively.
2) Allow Medicare to import drugs from abroad to encourage price competition (which I already do with my annual trips to Switzerland).
3) Ban drug companies from using government grants to pay for sales and advertising.
4) Set an out of pocket limit for drugs bought through Obamacare at $250 a month, thus ending customers? blank checks.
5) Set a 20% of revenue minimum which companies must spend on research and development.

She certainly got our attention.

Competition in the drug industry? Yikes! Not what the shareholders had in mind.

Raise your hand if you think Americans aren?t paying enough for their prescription drugs.

Yes, I thought so.

Drug company CEOs aren?t helping their case by flying to press conferences to complain about the proposals in brand new $65 million Cessna G-5?s.

And that Mylan CEO, Heather Bresch? She took home $18 million last year, and she?s just a kid.

Here?s the key issue for health care and biotech for investors. It all about politics.

Even if Hillary does get elected, the government is likely to remain gridlocked for another 4-8 years. The Democrats will almost certainly retake the Senate in 2016, thanks to a highly favorable calendar, and keep it for at least two years.

But the heavily gerrymandered House is another story.

With the current districting map, the Democrats would have to win 57% of the national vote for them to regain a majority in both houses.

That is a feat even Barack Obama could not pull off in 2008, when a perfect storm in favor of his party blew in.

A Hillary appointed liberal Supreme Court could bring an end to gerrymandering, but that is a multiyear process. Texas hasn?t had a legal districting map since 2000.

Even with Democratic control of congress, Hillary won?t get everything she wants.

Remember, Obamacare passed by one vote only after a year of cantankerous infighting, and then, only when a member changed parties (Pennsylvanian Arlen Spector).

That means few, if any, Clinton proposals will ever make it into law. If they do, they will be severely watered down and subject to the usual horse-trading and quid pro quos.

Beyond what she can accomplish through executive order, her election may be largely symbolic.

Therefore, the biotech and health care stocks are a screaming ?BUY? at these levels, provided you ignore Mylan (MYL), now the poster boy for corporate greed.

It?s a political call I can only make after spending years in the White House and a half century following presidential elections.

It?s easy to understand why these stocks were so popular, and are found brimming to overflowing in client portfolios and personal 401ks and IRAs.

We are just entering a Golden Age for biotech and health care.

Profit growth for many firms is exceeding 20% a year. Hyper accelerating biotechnology is rapidly bringing to market dozens of billion dollar earning drugs that were, until recently, considered in the realm of science fiction.

And we have only just gotten started. Cures for cancer, heart disease, arthritis, diabetes, AIDS, and dementia? You can take your pick.

Most biotech and health care stocks have given up all of their 2015 gains. Here is a chance to hoover up the fastest growing companies in the US at 2014 prices.

If you missed biotech and health care the first time around, you?ve just been given a second chance at the brass ring.

Here?s a list of five top quality names to get your feet wet:

Gilead Sciences (GILD) ? Has the world?s top hepatitis cure, which it sells for $80,000 per treatment. For a full report, see the next piece below.

Celgene (CELG) ? A biotech firm that specializes in cancer cures (thalidomide) and inflammatory diseases. It also produces Ritalin for the treatment of ADHD.

Allergan (AGN) ? Has the world?s third largest low cost generic drug business. In addition, it has built a major portfolio of drug therapies through more than two dozen acquisitions over the last decade.

Regeneron (REGN) ? Already has a great anti-inflammatory drug, and is about to market a blockbuster anti cholesterol drug that will substantially reduce heart disease.

HCA Holdings (HCA) ? Is the world?s largest operator of for profit health care facilities in the world.

If you want a lower risk, more diversified play in the area, you can buy the Health Care Select Sector SPDR (XLV). Please note that a basket of stocks is going to deliver a fraction of the volatility of single stocks.

Therefore, we have to be more aggressive with our positioning to make any money, picking call option strikes that are closer to the money.

Johnson and Johnson (JJ) is the largest holding in the (XLV), with a 12.8% weighting, while Gilead Sciences (GILD) is the fourth, with a 5.1% share. For a list of the largest components of this ETF, please click: https://www.spdrs.com/product/fund.seam?ticker=XLV.

The other classic play in this area is the Biotech iShares ETF (IBB) issued by BlackRock (click their link: https://www.ishares.com/us/products/239699/ishares-nasdaq-biotechnology-etf ).

Their largest holding is Biogen (BIIB), followed by Gilead Sciences (GILD), Celgene (CELG), Amgen (AMGN), and Regeneron Pharmaceutical (REGN).

I?ll be shooting out Trade Alerts on biotech and health care names as soon as I think the coast is clear.

Until then, enjoy the ride!

MYL
HCA
CELG
XLV
IBB
EpiPen

Say You Were A Biotech Investor, Did You?

https://www.madhedgefundtrader.com/wp-content/uploads/2015/10/EpiPen-e1472773044918.jpg 375 400 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2016-09-02 01:06:052016-09-02 01:06:05Biotech and Health Care Stocks to Buy at the Bottom
DougD

September 1, 2016

Diary, Newsletter, Summary

Global Market Comments
September 1, 2016
Fiat Lux

Featured Trade:
(PUBLISHING ?TRADING OPTIONS FOR BEGINNERS?),
(OCTOBER 21st SAN FRANCISCO, CA GLOBAL STRATEGY LUNCHEON),
(SEVEN REASONS TO PANIC ABOUT APPLE),
(AAPL), (QQQ)

Apple Inc. (AAPL)
PowerShares QQQ ETF (QQQ)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 DougD https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png DougD2016-09-01 01:09:532016-09-01 01:09:53September 1, 2016
DougD

August 31, 2016

Diary, Newsletter, Summary

Global Market Comments
August 31, 2016
Fiat Lux

Featured Trade:
(INTRODUCING THE MAD OPTIONS TRADER SERVICE),
(SEPTEMBER 16TH PORTLAND, OR GLOBAL STRATEGY LUNCHEON),

(THE LONG VIEW ON EMERGING MARKETS),
(EEM), (RSX), (EPHE), (PIN)

iShares MSCI Emerging Markets (EEM)
VanEck Vectors Russia ETF (RSX)
iShares MSCI Philippines (EPHE)
PowerShares India ETF (PIN)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 DougD https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png DougD2016-08-31 01:08:422016-08-31 01:08:42August 31, 2016
Page 437 of 678«‹435436437438439›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
  • Privacy Policy
  • Disclaimer
  • FAQ
Scroll to top